BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3948608)

  • 1. Malignancy index based on flow cytometry and histology for renal cell carcinomas and its correlation to prognosis.
    Baisch H; Otto U; Klöppel G
    Cytometry; 1986 Mar; 7(2):200-4. PubMed ID: 3948608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic parameters of renal cell carcinoma. Clinicopathologic and DNA image cytometric analysis in 133 pT3a cases.
    Steinbach F; Stöckle M; Kiewel R; Störkel S; Stein R; Hohenfellner R
    Eur Urol; 1993; 24(2):279-85. PubMed ID: 8375451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Flow cytometric DNA analysis of renal cell carcinoma and its relationship to tumor grading, tumor stage and prognosis].
    Hara H; Tanioka F
    Rinsho Byori; 1993 Jun; Suppl 94():76-88. PubMed ID: 8361010
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA cytometry in renal cell carcinoma.
    Nenning H; Rassler J; Minh DH
    Gen Diagn Pathol; 1996 Mar; 141(3-4):243-7. PubMed ID: 8705789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term serial transplantation of 30 different human renal cell carcinomas into NMRI (nu/nu) mice: flow cytometric, histologic, and growth studies.
    Baisch H; Otto U; Klöppel G
    J Natl Cancer Inst; 1986 Feb; 76(2):269-76. PubMed ID: 2418248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibilities of DNA impulse cytophotometry in kidney cancers].
    Kiesewetter F; Hornstein OP; Hermanek P; Herrlinger A; Eberhard S
    Urologe A; 1987 May; 26(3):162-7. PubMed ID: 3603902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary apoptosis as a prognostic index for the classification of metastatic renal cell carcinoma.
    Richter EN; Oevermann K; Buentig N; Storkel S; Dallmann I; Atzpodien J
    J Urol; 2002 Aug; 168(2):460-4. PubMed ID: 12131288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading of human renal adenocarcinoma.
    Syrjänen K; Hjelt L
    Scand J Urol Nephrol; 1978; 12(1):49-55. PubMed ID: 635486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
    Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
    Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The indications for adrenalectomy in the surgical treatment of renal-cell cancer].
    Serniak IuP
    Urol Nefrol (Mosk); 1997; (6):40-3. PubMed ID: 9461788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of morphologic signs of primary tumor for the prognosis of metastases of renal cell carcinoma].
    Vlodavskii EA
    Urol Nefrol (Mosk); 1989; (2):25-7. PubMed ID: 2728136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and flow cytometric analyses of renal cell carcinomas with reference to incidental or non-incidental detection.
    Sasaki Y; Homma Y; Hosaka Y; Tajima A; Aso Y
    Jpn J Clin Oncol; 1994 Feb; 24(1):32-6. PubMed ID: 8126918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with renal cell carcinoma.
    Fiori E; De Cesare A; Galati G; Bononi M; D'Andrea N; Barbarosos A; Izzo L; Bolognese A
    J Exp Clin Cancer Res; 2002 Jun; 21(2):229-32. PubMed ID: 12148583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.